CLRB
Price
$2.74
Change
-$0.08 (-2.84%)
Updated
Jul 13, 11:48 AM (EDT)
Capitalization
22.54M
37 days until earnings call
Intraday BUY SELL Signals
GOVX
Price
$1.15
Change
-$0.03 (-2.54%)
Updated
Jul 13, 11:51 AM (EDT)
Capitalization
6.15M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLRB vs GOVX

CLRB vs GOVX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLRB vs. GOVX commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a StrongBuy and GOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2026
Stock price -- (CLRB: $2.82 vs. GOVX: $1.18)
Brand notoriety: CLRB and GOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 22% vs. GOVX: 1%
Market capitalization -- CLRB: $22.54M vs. GOVX: $6.15M
CLRB [@Biotechnology] is valued at $22.54M. GOVX’s [@Biotechnology] market capitalization is $6.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $123.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileGOVX’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • GOVX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLRB is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 6 TA indicator(s) are bullish while GOVX’s TA Score has 3 bullish TA indicator(s).

  • CLRB’s TA Score: 6 bullish, 3 bearish.
  • GOVX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than GOVX.

Price Growth

CLRB (@Biotechnology) experienced а +0.36% price change this week, while GOVX (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.42%. For the same industry, the average monthly price growth was +13.23%, and the average quarterly price growth was +1883.80%.

Reported Earning Dates

CLRB is expected to report earnings on Aug 19, 2026.

GOVX is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-0.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRB($22.5M) has a higher market cap than GOVX($6.15M). CLRB YTD gains are higher at: -4.407 vs. GOVX (-72.398). GOVX (-21.27M) and CLRB (-22.33M) have comparable annual earnings (EBITDA) . CLRB has more cash in the bank: 8.35M vs. GOVX (1.27M). GOVX has less debt than CLRB: GOVX (395K) vs CLRB (1.53M). GOVX has higher revenues than CLRB: GOVX (852K) vs CLRB (0).
CLRBGOVXCLRB / GOVX
Capitalization22.5M6.15M366%
EBITDA-22.33M-21.27M105%
Gain YTD-4.407-72.3986%
P/E RatioN/AN/A-
Revenue0852K-
Total Cash8.35M1.27M656%
Total Debt1.53M395K387%
FUNDAMENTALS RATINGS
CLRB vs GOVX: Fundamental Ratings
CLRB
GOVX
OUTLOOK RATING
1..100
5076
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5084
P/E GROWTH RATING
1..100
71100
SEASONALITY SCORE
1..100
4590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOVX's Valuation (55) in the null industry is in the same range as CLRB (76) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CLRB’s over the last 12 months.

GOVX's Profit vs Risk Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CLRB’s over the last 12 months.

GOVX's SMR Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CLRB’s over the last 12 months.

CLRB's Price Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for GOVX (84) in the null industry. This means that CLRB’s stock grew somewhat faster than GOVX’s over the last 12 months.

CLRB's P/E Growth Rating (71) in the Biotechnology industry is in the same range as GOVX (100) in the null industry. This means that CLRB’s stock grew similarly to GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBGOVX
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLRB
Daily Signal:
Gain/Loss:
GOVX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIV13.940.49
+3.64%
Telefonica Brasil SA
KRT34.180.14
+0.41%
Karat Packaging
SSM4.090.01
+0.37%
Sono Group NV
WSBK13.05-0.05
-0.38%
Winchester Bancorp Inc
RHI32.40-0.20
-0.61%
Robert Half

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with QTTB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
+1.81%
QTTB - CLRB
62%
Loosely correlated
-10.96%
ADCT - CLRB
43%
Loosely correlated
-0.77%
RKTO - CLRB
42%
Loosely correlated
-1.36%
OGEN - CLRB
41%
Loosely correlated
+1.68%
ANAB - CLRB
40%
Loosely correlated
-0.30%
More

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with TOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then TOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
+0.85%
TOVX - GOVX
54%
Loosely correlated
+3.16%
GRI - GOVX
37%
Loosely correlated
-2.25%
OGEN - GOVX
33%
Poorly correlated
+1.68%
MAIA - GOVX
32%
Poorly correlated
-1.37%
CLRB - GOVX
31%
Poorly correlated
+1.81%
More